speb/financial-data huggingface dataset:
MSF.DE balance_sheet (annual, 2025-06-30) — Current Deferred Revenue: 64555000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 64555000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Current Liabilities: 141218000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 141218000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Deferred Income Tax: -7056000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -2221000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Deferred Tax: -7056000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Deferred Tax: -2221000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Depreciation: 34153000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Depreciation: 11203000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Depreciation Amortization Depletion: 34153000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 11203000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Depreciation And Amortization: 34153000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 11203000000.00
MSF.DE income_statement (annual, 2025-06-30) — Diluted Average Shares: 7465000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 7461000000.00
MSF.DE income_statement (annual, 2025-06-30) — Diluted EPS: 13.64
MSF.DE income_statement (quarterly, 2025-06-30) — Diluted EPS: 3.65
MSF.DE income_statement (annual, 2025-06-30) — Diluted NI Availto Com Stockholders: 101832000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 27233000000.00
MSF.DE income_statement (annual, 2025-06-30) — EBIT: 126012000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — EBIT: 33231000000.00
MSF.DE income_statement (annual, 2025-06-30) — EBITDA: 160165000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — EBITDA: 44434000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Effect Of Exchange Rate Changes: 63000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 183000000.00
MSF.DE cash_flow (annual, 2025-06-30) — End Cash Position: 30242000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — End Cash Position: 30242000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Financial Assets: 272000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Financial Assets: 272000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Financing Cash Flow: -51699000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -10844000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Free Cash Flow: 71611000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 25568000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Gain Loss On Investment Securities: 202000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -25000000.00
MSF.DE income_statement (annual, 2025-06-30) — Gain On Sale Of Security: 505000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 48000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -3347000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -3347000000.00
MSF.DE income_statement (annual, 2025-06-30) — General And Administrative Expense: 7223000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1990000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Goodwill: 119509000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Goodwill: 119509000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Goodwill And Other Intangible Assets: 142113000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 142113000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Gross Accounts Receivable: 70849000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 70849000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Gross PPE: 323442000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Gross PPE: 323442000000.00
MSF.DE income_statement (annual, 2025-06-30) — Gross Profit: 193893000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Gross Profit: 52427000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Hedging Assets Current: 10000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 10000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Income Tax Payable: 7211000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 7211000000.00
MSF.DE income_statement (annual, 2025-06-30) — Interest Expense: 2385000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Interest Expense: 615000000.00
MSF.DE income_statement (annual, 2025-06-30) — Interest Expense Non Operating: 2385000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 615000000.00
MSF.DE income_statement (annual, 2025-06-30) — Interest Income: 2647000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Interest Income: 769000000.00
MSF.DE income_statement (annual, 2025-06-30) — Interest Income Non Operating: 2647000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 769000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Inventory: 938000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Inventory: 938000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Invested Capital: 386630000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 386630000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Investing Cash Flow: -72599000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -30572000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Investmentin Financial Assets: 2460000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 2460000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Investments And Advances: 15133000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 15133000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Issuance Of Capital Stock: 2056000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 548000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Issuance Of Debt: 0.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
MSF.DE balance_sheet (annual, 2025-06-30) — Land And Improvements: 9338000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 9338000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Leases: 12117000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Leases: 12117000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Long Term Capital Lease Obligation: 17437000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 17437000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Long Term Debt: 40152000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 40152000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 57589000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 57589000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Long Term Debt Issuance: 0.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
MSF.DE cash_flow (annual, 2025-06-30) — Long Term Debt Payments: -3216000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 0.00
MSF.DE balance_sheet (annual, 2025-06-30) — Long Term Equity Investment: 12673000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 12673000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Machinery Furniture Equipment: 139243000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 139243000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Net Business Purchase And Sale: -5978000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -1743000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Net Common Stock Issuance: -16364000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -3998000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Net Debt: 12909000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Net Debt: 12909000000.00
MSF.DE income_statement (annual, 2025-06-30) — Net Income: 101832000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Net Income: 27233000000.00
MSF.DE income_statement (annual, 2025-06-30) — Net Income Common Stockholders: 101832000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 27233000000.00
MSF.DE income_statement (annual, 2025-06-30) — Net Income Continuous Operations: 101832000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 27233000000.00
MSF.DE income_statement (annual, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 101832000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 27233000000.00
MSF.DE income_statement (annual, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 101832000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 27233000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Net Income From Continuing Operations: 101832000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 27233000000.00
MSF.DE income_statement (annual, 2025-06-30) — Net Income Including Noncontrolling Interests: 101832000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 27233000000.00
MSF.DE income_statement (annual, 2025-06-30) — Net Interest Income: 262000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Net Interest Income: 154000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Net Investment Purchase And Sale: -4387000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -14392000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Net Issuance Payments Of Debt: -8962000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
MSF.DE cash_flow (annual, 2025-06-30) — Net Long Term Debt Issuance: -3216000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 0.00
MSF.DE income_statement (annual, 2025-06-30) — Net Non Operating Interest Income Expense: 262000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 154000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Net Other Financing Charges: -2291000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -677000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Net Other Investing Changes: 2317000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 2642000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Net PPE: 229789000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Net PPE: 229789000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Net PPE Purchase And Sale: -64551000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -17079000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Net Short Term Debt Issuance: -5746000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 0.00
MSF.DE balance_sheet (annual, 2025-06-30) — Net Tangible Assets: 201366000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 201366000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Non Current Deferred Liabilities: 5545000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 5545000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Non Current Deferred Revenue: 2710000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 2710000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Non Current Deferred Taxes Liabilities: 2835000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 2835000000.00
MSF.DE income_statement (annual, 2025-06-30) — Normalized EBITDA: 160603000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 44431000000.00
MSF.DE income_statement (annual, 2025-06-30) — Normalized Income: 102192912000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Normalized Income: 27230495125.09
MSF.DE cash_flow (annual, 2025-06-30) — Operating Cash Flow: 136162000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 42647000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Operating Gains Losses: 202000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -25000000.00
MSF.DE income_statement (annual, 2025-06-30) — Operating Income: 128528000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Operating Income: 34323000000.00
MSF.DE income_statement (annual, 2025-06-30) — Operating Revenue: 281724000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Operating Revenue: 76441000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Ordinary Shares Number: 7434158655.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 7434158655.00
MSF.DE balance_sheet (annual, 2025-06-30) — Other Current Assets: 25723000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 25723000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Other Current Borrowings: 2999000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 2999000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Other Current Liabilities: 25020000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 25020000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Other Equity Adjustments: -3347000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -3347000000.00
MSF.DE income_statement (annual, 2025-06-30) — Other Gand A: 7223000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Other Gand A: 1990000000.00
MSF.DE income_statement (annual, 2025-06-30) — Other Income Expense: -5163000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Other Income Expense: -1861000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Other Intangible Assets: 22604000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 22604000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Other Non Current Assets: 40565000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 40565000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Other Non Current Liabilities: 45186000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 45186000000.00
MSF.DE income_statement (annual, 2025-06-30) — Other Non Operating Income Expenses: -4725000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -1864000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Other Properties: 24823000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Other Properties: 24823000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Other Short Term Investments: 64313000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 64313000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Payables: 34935000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Payables: 34935000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Payables And Accrued Expenses: 34935000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 34935000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 13709000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 13709000000.00
MSF.DE income_statement (annual, 2025-06-30) — Pretax Income: 123627000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Pretax Income: 32616000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Properties: 0.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
MSF.DE cash_flow (annual, 2025-06-30) — Purchase Of Business: -5978000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -1743000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Purchase Of Investment: -29775000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -21631000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Purchase Of PPE: -64551000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -17079000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Receivables: 69905000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Receivables: 69905000000.00
MSF.DE income_statement (annual, 2025-06-30) — Reconciled Cost Of Revenue: 87831000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 24014000000.00
MSF.DE income_statement (annual, 2025-06-30) — Reconciled Depreciation: 34153000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 11203000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Repayment Of Debt: -3216000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: 0.00
MSF.DE cash_flow (annual, 2025-06-30) — Repurchase Of Capital Stock: -18420000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -4546000000.00
MSF.DE income_statement (annual, 2025-06-30) — Research And Development: 32488000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Research And Development: 8829000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Retained Earnings: 237731000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 237731000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Sale Of Investment: 25388000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 7239000000.00
MSF.DE income_statement (annual, 2025-06-30) — Selling And Marketing Expense: 25654000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 7285000000.00
MSF.DE income_statement (annual, 2025-06-30) — Selling General And Administration: 32877000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 9275000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Share Issued: 7434158655.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Share Issued: 7434158655.00
MSF.DE income_statement (annual, 2025-06-30) — Special Income Charges: -943000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Special Income Charges: -45000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Stock Based Compensation: 11974000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 3073000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Stockholders Equity: 343479000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 343479000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Tangible Book Value: 201366000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 201366000000.00
MSF.DE income_statement (annual, 2025-06-30) — Tax Effect Of Unusual Items: -77088000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 495125.09
MSF.DE income_statement (annual, 2025-06-30) — Tax Provision: 21795000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Tax Provision: 5383000000.00
MSF.DE income_statement (annual, 2025-06-30) — Tax Rate For Calcs: 0.18
MSF.DE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.17
MSF.DE balance_sheet (annual, 2025-06-30) — Total Assets: 619003000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Total Assets: 619003000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Total Capitalization: 383631000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 383631000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Total Debt: 60588000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Total Debt: 60588000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Total Equity Gross Minority Interest: 343479000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 343479000000.00
MSF.DE income_statement (annual, 2025-06-30) — Total Expenses: 153196000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Total Expenses: 42118000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Total Liabilities Net Minority Interest: 275524000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 275524000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Total Non Current Assets: 427872000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 427872000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 134306000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 134306000000.00
MSF.DE income_statement (annual, 2025-06-30) — Total Operating Income As Reported: 128528000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 34323000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Total Tax Payable: 7211000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 7211000000.00
MSF.DE income_statement (annual, 2025-06-30) — Total Unusual Items: -438000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Total Unusual Items: 3000000.00
MSF.DE income_statement (annual, 2025-06-30) — Total Unusual Items Excluding Goodwill: -438000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 3000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Tradeand Other Payables Non Current: 25986000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 25986000000.00
MSF.DE cash_flow (annual, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -536000000.00
MSF.DE cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 36000000.00
MSF.DE balance_sheet (annual, 2025-06-30) — Working Capital: 49913000000.00
MSF.DE balance_sheet (quarterly, 2025-06-30) — Working Capital: 49913000000.00
MSF.DE income_statement (annual, 2025-06-30) — Write Off: 943000000.00
MSF.DE income_statement (quarterly, 2025-06-30) — Write Off: 45000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — +Operating Expense: 15669000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — +Total Revenue: 77673000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 32580000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 52894000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -98880000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -687000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 14000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 2510000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 30242000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 152433000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -19394000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 17348000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 110964000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 28849000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 102005000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -6169000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 17483000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Cash Financial: 11366000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -11799000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -34559000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 45057000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -614000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Change In Inventory: -192000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -1556000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -5984000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -8362000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Change In Payable: -614000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -614000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Change In Receivables: 16490000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -218000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 16490000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1301000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Common Stock: 110964000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -6169000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 363076000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 689000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -5650000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 24043000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Current Assets: 189066000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Current Debt: 7832000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 7832000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 58987000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 58987000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 134996000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 2491000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Deferred Tax: 2491000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Depreciation: 13061000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 13061000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 13061000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 27747000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — EBIT: 34999000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — EBITDA: 48060000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -92000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — End Cash Position: 28849000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Financial Assets: 1182000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 7773000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -11799000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 25663000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -1656000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 999000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -2761000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1806000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Goodwill: 119497000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 140733000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 53581000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Gross PPE: 354532000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Gross Profit: 53630000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 7000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 3655000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Interest Expense: 698000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 698000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Interest Income: 976000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 976000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Inventory: 1130000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 406284000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -34559000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 10283000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 10283000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 689000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 9450000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Leases: 13610000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 17348000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 35376000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 52724000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 154248000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -578000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -4961000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Net Debt: 14359000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Net Income: 27747000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 27747000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 27747000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 27747000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 27747000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 27747000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 27747000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Net Interest Income: 278000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -8378000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
MSF.DE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 278000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -669000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -6209000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Net PPE: 255652000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -19394000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 0.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 222343000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 5398000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 2546000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 2852000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 47075000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Normalized Income: 26949150000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 45057000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -1656000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Operating Income: 37961000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Operating Revenue: 77673000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 7433087554.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 33030000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 22741000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -2761000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Other Gand A: 1806000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Other Income Expense: -3938000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 21236000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 39435000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 53588000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -4923000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Other Properties: 24791000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 73156000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Payables: 36235000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 36235000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 9201000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Pretax Income: 34301000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -578000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -17671000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -19394000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Receivables: 52894000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 24043000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 13061000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -5650000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Research And Development: 8146000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 254873000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 9293000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 5717000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Selling General And Administration: 7523000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Share Issued: 7433087554.00
MSF.DE income_statement (quarterly, 2025-09-30) — Special Income Charges: -14000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2983000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 363076000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 222343000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 187150000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Tax Provision: 6554000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.19
MSF.DE balance_sheet (quarterly, 2025-09-30) — Total Assets: 636351000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 398452000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Total Debt: 60556000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 363076000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Total Expenses: 39712000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 273275000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 447285000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 138279000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 37961000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 3655000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Total Unusual Items: 985000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 985000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 26569000000.00
MSF.DE cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 635000000.00
MSF.DE balance_sheet (quarterly, 2025-09-30) — Working Capital: 54070000000.00
MSF.DE income_statement (quarterly, 2025-09-30) — Write Off: 14000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — +Operating Expense: 17020000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — +Total Revenue: 81273000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 37328000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 56535000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -104950000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -729000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 1620000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Basic Average Shares: 7431000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Basic EPS: 5.18
MSF.DE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 28849000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 163986000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -29876000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 17345000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 112788000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 24296000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 89456000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -6762000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 14075000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Cash Financial: 10221000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -17617000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -22705000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 35758000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1197000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Change In Inventory: 70000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -669000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 1609000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -8403000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Change In Payable: 1197000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 1197000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Change In Receivables: -3436000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -9632000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -3436000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Changes In Cash: -4564000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Common Stock: 112788000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -6762000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 390875000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 259000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -7415000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 25978000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Current Assets: 180190000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Current Debt: 4837000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 4837000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 51376000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 51376000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 130005000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 4446000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Deferred Tax: 4446000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Depreciation: 9198000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 9198000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 9198000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 7460000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Diluted EPS: 5.16
MSF.DE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 38458000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — EBIT: 48982000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — EBITDA: 58180000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 11000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — End Cash Position: 24296000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Financial Assets: 0.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 19582000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -17617000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 5882000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 385000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2702000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1932000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Goodwill: 119622000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 139911000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 57264000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 391179000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Gross Profit: 55295000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 6000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 2050000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Interest Expense: 736000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 736000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Interest Income: 840000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 840000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Inventory: 1059000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 431137000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -22705000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 21202000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 21202000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 259000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 9698000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Leases: 14500000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 17345000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 35425000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 52770000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -3000000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 177892000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -455000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -7156000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Net Debt: 15966000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Net Income: 38458000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 38458000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 38458000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 38458000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 38458000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 38458000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 38458000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Net Interest Income: 104000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 8263000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -3000000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -3000000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 104000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -699000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -637000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Net PPE: 286229000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -29876000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 0.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 250964000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 5544000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 2668000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2876000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 57854000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Normalized Income: 38197200000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 35758000000.00
MSF.DE cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -9931000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Operating Income: 38275000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Operating Revenue: 81273000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 7428838066.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 33134000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 24311000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -2702000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Other Gand A: 1932000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Other Income Expense: 9867000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 20289000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 37770000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 58852000000.00
MSF.DE income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 9541000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Other Properties: 25103000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 65160000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Payables: 39378000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 39378000000.00
MSF.DE balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 10103000000.00